SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-019624
Filing Date
2023-12-07
Accepted
2023-12-07 16:06:27
Documents
17
Period of Report
2023-10-10
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hrmy-20231010x8ka.htm   iXBRL 8-K/A 45057
2 EX-23.1 hrmy-20231010xex23d1.htm EX-23.1 2520
3 EX-99.1 hrmy-20231010xex99d1.htm EX-99.1 732114
4 EX-99.2 hrmy-20231010xex99d2.htm EX-99.2 832197
5 EX-99.2 hrmy-20231010xex99d3.htm EX-99.3 774140
6 GRAPHIC hrmy-20231010x8ka001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-23-019624.txt   2651304

Data Files

Seq Description Document Type Size
7 EX-101.SCH hrmy-20231010.xsd EX-101.SCH 3163
8 EX-101.LAB hrmy-20231010_lab.xml EX-101.LAB 15928
9 EX-101.PRE hrmy-20231010_pre.xml EX-101.PRE 10081
11 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20231010x8ka_htm.xml XML 4929
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39450 | Film No.: 231472413
SIC: 2834 Pharmaceutical Preparations